Pulmonology Medical News about lung transplant

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Evaluation of interleukin-6 and interleukin-10 in lung transplant patients with human cytomegalovirus infection
Clinical Transplantation, 07/20/09

Zedtwitz–Liebenstein K et al. – The data suggest that IL–6 does not serve as a good diagnostic parameter for existence of HCMV infection in lung transplant patients. Because of the wide range of the IL–6 levels in both groups, the authors were not able to find a breakpoint differentiating between infected and not–infected patients. Another important finding was that IL–6 production is not dependent of the HCMV status of D/R.

<< Previous
Spectrum of practice in the diagnosis of nosocomial pneumonia in...

Next >>
Molecular analysis of Mycobacterium tuberculosis from tuberculous...